9,525,000 Shares Fate Therapeutics, Inc. COMMON STOCK, PAR VALUE $0.001 PER SHARE UNDERWRITING AGREEMENTUnderwriting Agreement • December 14th, 2017 • Fate Therapeutics Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledDecember 14th, 2017 Company Industry Jurisdiction